Copyright Reports & Markets. All rights reserved.

Global NK Cell Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global NK Cell Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 NK Cell Therapies
      • 1.4.3 NK Cell Directed Antibodies
    • 1.5 Market by Application
      • 1.5.1 Global NK Cell Therapy Market Share by Application (2019-2025)
      • 1.5.2 Cancer
      • 1.5.3 Gastrointestinal Diseases
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 NK Cell Therapy Market Size
    • 2.2 NK Cell Therapy Growth Trends by Regions
      • 2.2.1 NK Cell Therapy Market Size by Regions (2019-2025)
      • 2.2.2 NK Cell Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 NK Cell Therapy Market Size by by Players
      • 3.1.1 Global NK Cell Therapy Revenue by by Players (2014-2019)
      • 3.1.2 Global NK Cell Therapy Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 NK Cell Therapy Key Players Head office and Area Served
    • 3.3 Key Players NK Cell Therapy Product/Solution/Service
    • 3.4 Date of Enter into NK Cell Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global NK Cell Therapy Market Size by Type (2014-2019)
    • 4.2 Global NK Cell Therapy Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America NK Cell Therapy Market Size (2014-2019)
    • 5.2 NK Cell Therapy Key Players in North America
    • 5.3 North America NK Cell Therapy Market Size by Type
    • 5.4 North America NK Cell Therapy Market Size by Application

    6 Europe

    • 6.1 Europe NK Cell Therapy Market Size (2014-2019)
    • 6.2 NK Cell Therapy Key Players in Europe
    • 6.3 Europe NK Cell Therapy Market Size by Type
    • 6.4 Europe NK Cell Therapy Market Size by Application

    7 China

    • 7.1 China NK Cell Therapy Market Size (2014-2019)
    • 7.2 NK Cell Therapy Key Players in China
    • 7.3 China NK Cell Therapy Market Size by Type
    • 7.4 China NK Cell Therapy Market Size by Application

    8 Japan

    • 8.1 Japan NK Cell Therapy Market Size (2014-2019)
    • 8.2 NK Cell Therapy Key Players in Japan
    • 8.3 Japan NK Cell Therapy Market Size by Type
    • 8.4 Japan NK Cell Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia NK Cell Therapy Market Size (2014-2019)
    • 9.2 NK Cell Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia NK Cell Therapy Market Size by Type
    • 9.4 Southeast Asia NK Cell Therapy Market Size by Application

    10 India

    • 10.1 India NK Cell Therapy Market Size (2014-2019)
    • 10.2 NK Cell Therapy Key Players in India
    • 10.3 India NK Cell Therapy Market Size by Type
    • 10.4 India NK Cell Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America NK Cell Therapy Market Size (2014-2019)
    • 11.2 NK Cell Therapy Key Players in Central & South America
    • 11.3 Central & South America NK Cell Therapy Market Size by Type
    • 11.4 Central & South America NK Cell Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 Nektar Therapeutics
      • 12.1.1 Nektar Therapeutics Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 NK Cell Therapy Introduction
      • 12.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2014-2019))
      • 12.1.5 Nektar Therapeutics Recent Development
    • 12.2 Innate Pharma SA
      • 12.2.1 Innate Pharma SA Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 NK Cell Therapy Introduction
      • 12.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2014-2019)
      • 12.2.5 Innate Pharma SA Recent Development
    • 12.3 Affimed
      • 12.3.1 Affimed Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 NK Cell Therapy Introduction
      • 12.3.4 Affimed Revenue in NK Cell Therapy Business (2014-2019)
      • 12.3.5 Affimed Recent Development
    • 12.4 Chipscreen Biosciences
      • 12.4.1 Chipscreen Biosciences Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 NK Cell Therapy Introduction
      • 12.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2014-2019)
      • 12.4.5 Chipscreen Biosciences Recent Development
    • 12.5 Fate Therapeutics
      • 12.5.1 Fate Therapeutics Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 NK Cell Therapy Introduction
      • 12.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2014-2019)
      • 12.5.5 Fate Therapeutics Recent Development
    • 12.6 Glycostem Therapeutics
      • 12.6.1 Glycostem Therapeutics Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 NK Cell Therapy Introduction
      • 12.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2014-2019)
      • 12.6.5 Glycostem Therapeutics Recent Development
    • 12.7 Dragonfly Therapeutics
      • 12.7.1 Dragonfly Therapeutics Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 NK Cell Therapy Introduction
      • 12.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2014-2019)
      • 12.7.5 Dragonfly Therapeutics Recent Development
    • 12.8 Kiadis Pharma
      • 12.8.1 Kiadis Pharma Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 NK Cell Therapy Introduction
      • 12.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2014-2019)
      • 12.8.5 Kiadis Pharma Recent Development
    • 12.9 NantWorks
      • 12.9.1 NantWorks Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 NK Cell Therapy Introduction
      • 12.9.4 NantWorks Revenue in NK Cell Therapy Business (2014-2019)
      • 12.9.5 NantWorks Recent Development
    • 12.10 Nkarta Therapeutics
      • 12.10.1 Nkarta Therapeutics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 NK Cell Therapy Introduction
      • 12.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2014-2019)
      • 12.10.5 Nkarta Therapeutics Recent Development
    • 12.11 Fortress Biotech

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global NK Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the NK Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Nektar Therapeutics
      Innate Pharma SA
      Affimed
      Chipscreen Biosciences
      Fate Therapeutics
      Glycostem Therapeutics
      Dragonfly Therapeutics
      Kiadis Pharma
      NantWorks
      Nkarta Therapeutics
      Fortress Biotech

      Market segment by Type, the product can be split into
      NK Cell Therapies
      NK Cell Directed Antibodies

      NK Cell agents took the largest market share segment, accounting for 82% and growing fastest

      Market segment by Application, split into
      Cancer
      Gastrointestinal Diseases
      Others

      Cancer was the most widely used area at 66%

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global NK Cell Therapy status, future forecast, growth opportunity, key market and key players.
      To present the NK Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of NK Cell Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now